Bioptamers

Manufacturing · Delaware, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

New Castle, Delaware, United States

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Bioptamers

Bioptamers, Inc. specializes in personalized precision therapies aimed at improving outcomes for cancer patients through targeted drug delivery systems. Their innovative approach utilizes aptamer technology to create personalized molecules that specifically identify cancer cells, making treatments more effective and cost-efficient compared to traditional therapies. The company collaborates with universities, private companies, and hospitals to accelerate the development and marketing of their therapies. With a focus on industrializing synthetic molecules and expanding their intellectual property, Bioptamers is committed to advancing cancer treatment solutions.Explore more
Bioptamers's Social MediaPopular SearchesBioptamersBioptamers IncSIC Code 28,283NAICS Code 32,325Show more

Bioptamers Org Chart

Erika Molina, Chief Executive Officer at Bioptamers
United States flag for contact location.

Chief Executive Officer

PhoneEmail
TD
United States flag for contact location.

Scientific Researcher

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Bioptamers your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Bioptamers

Compare insights from companies similar to Bioptamers, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Bioptamers

<$5M
1-10
Private
-
2018
<$5M
11-50
Private
-
1998
PL
Phillip LiuSenior Director
<$5M
11-50
Private
-
1998
N/A
<$5M
1-10
Private
-
2015
<$5M
1-10
Private
-
2012
LH
Lauren HartmannManager, Clinical Trial & Consultant
<$5M
1-10
Private
<$5M
2002
Mazen Hanna, President at TransGenex Nanobiotech
Mazen HannaPresident
11-50
Public
$199.6M
1996
James Caruso, President, Chief Executive Officer & Director at Cellectar Biosciences
James CarusoPresident, CEO & Director
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Bioptamers is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Bioptamers is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bioptamers.

Bioptamers Tech Stack

A closer look at the technologies used by Bioptamers

Top Manufacturing Companies

Frequently Asked Questions Regarding Bioptamers

What is Bioptamers's official website?
Bioptamers's official website is www.bioptamers.com
What is Bioptamers's Revenue?
Bioptamers's revenue is <$5 Million
What is Bioptamers's SIC code?
Bioptamers's SIC: 28,283
What is Bioptamers's NAICS code?
Bioptamers's NAICS: 32,325
How many employees does Bioptamers have?
Bioptamers has 1-10 employees
What industry does Bioptamers belong to?
Bioptamers is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Bioptamers competition?
Bioptamers top competitors include: Sound Biologics, Pharmatest Services, Cellectar Biosciences, AdCure Bio
What technology does Bioptamers use?
Some of the popular technologies that Bioptamers uses are: JQuery 2.1.1, Google Cloud Web Serving, Google Cloud Platform, HubSpot
What does Bioptamers do?

Bioptamers, Inc. specializes in personalized precision therapies aimed at improving outcomes for cancer patients through targeted drug delivery systems. Their innovative approach utilizes aptamer technology to create personalized molecules that specifically identify cancer cells, making treatments more effective and cost-efficient compared to tradi... tional therapies. The company collaborates with universities, private companies, and hospitals to accelerate the development and marketing of their therapies. With a focus on industrializing synthetic molecules and expanding their intellectual property, Bioptamers is committed to advancing cancer treatment solutions.Read More

What are Bioptamers social media links?
Bioptamers Linkedin page Bioptamers Twitter page Bioptamers Facebook page
Is Bioptamers a public company?
Bioptamers is private company therefore does not currently have an official ticker symbol
See more information about Bioptamers

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.